PT1037666E - Metodo para aumentar a absorcao e o transporte de compostos lipidicos soluveis usando gliceridos estruturados - Google Patents
Metodo para aumentar a absorcao e o transporte de compostos lipidicos soluveis usando gliceridos estruturadosInfo
- Publication number
- PT1037666E PT1037666E PT98960729T PT98960729T PT1037666E PT 1037666 E PT1037666 E PT 1037666E PT 98960729 T PT98960729 T PT 98960729T PT 98960729 T PT98960729 T PT 98960729T PT 1037666 E PT1037666 E PT 1037666E
- Authority
- PT
- Portugal
- Prior art keywords
- carbon atoms
- acyl moieties
- transportation
- structured
- glyceride
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 238000010521 absorption reaction Methods 0.000 title abstract 2
- -1 LIPID COMPOUNDS Chemical class 0.000 title 1
- 125000002252 acyl group Chemical group 0.000 abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 125000005456 glyceride group Chemical group 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 150000002634 lipophilic molecules Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 241000894007 species Species 0.000 abstract 2
- 208000011231 Crohn disease Diseases 0.000 abstract 1
- 201000003883 Cystic fibrosis Diseases 0.000 abstract 1
- 206010025477 Malabsorption conditions Diseases 0.000 abstract 1
- 206010049416 Short-bowel syndrome Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
- C11C3/10—Ester interchange
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Medicinal Preparation (AREA)
- Edible Oils And Fats (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/991,503 US6013665A (en) | 1997-12-16 | 1997-12-16 | Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1037666E true PT1037666E (pt) | 2004-02-27 |
Family
ID=25537282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98960729T PT1037666E (pt) | 1997-12-16 | 1998-12-04 | Metodo para aumentar a absorcao e o transporte de compostos lipidicos soluveis usando gliceridos estruturados |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US6013665A (pt) |
| EP (1) | EP1037666B1 (pt) |
| JP (1) | JP2002508336A (pt) |
| AT (1) | ATE250938T1 (pt) |
| AU (1) | AU739233B2 (pt) |
| BR (1) | BR9813474A (pt) |
| CA (1) | CA2315224A1 (pt) |
| DE (1) | DE69818704T2 (pt) |
| DK (1) | DK1037666T3 (pt) |
| ES (1) | ES2209228T3 (pt) |
| HU (1) | HUP0100430A2 (pt) |
| IL (1) | IL135271A0 (pt) |
| NO (1) | NO20002306L (pt) |
| NZ (1) | NZ503666A (pt) |
| PL (1) | PL341208A1 (pt) |
| PT (1) | PT1037666E (pt) |
| TR (1) | TR200001563T2 (pt) |
| WO (1) | WO1999030740A1 (pt) |
Families Citing this family (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6979456B1 (en) | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
| KR100777647B1 (ko) * | 1998-08-19 | 2007-11-19 | 스키에파마 캐나다 인코포레이티드 | 프로포폴의 수용성 주사용 분산액 |
| US6835408B2 (en) | 1998-11-13 | 2004-12-28 | The Nisshin Oillio Group, Ltd. | Oil or fat composition |
| US20070244192A1 (en) * | 1999-01-14 | 2007-10-18 | Martek Biosciences Corporation | Plant seed oils containing polyunsaturated fatty acids |
| US7211418B2 (en) * | 1999-01-14 | 2007-05-01 | Martek Biosciences Corporation | PUFA polyketide synthase systems and uses thereof |
| US7247461B2 (en) * | 1999-01-14 | 2007-07-24 | Martek Biosciences Corporation | Nucleic acid molecule encoding ORFA of a PUFA polyketide synthase system and uses thereof |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| AU5249500A (en) * | 1999-06-18 | 2001-01-09 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Medicinal composition for oral administration |
| US20030236236A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
| US7732404B2 (en) * | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
| IL135335A (en) * | 2000-03-29 | 2013-12-31 | Lycored Natural Prod Ind Ltd | Use of carotenoids in the preparation of medicaments for preventing hormone induced adverse effects and pharmaceutical compositions comprising carotenoids |
| EP1372641A4 (en) * | 2001-03-05 | 2004-08-25 | Stephen P Ernest | ENTERAL FORMULATION |
| KR20020081632A (ko) * | 2001-04-19 | 2002-10-30 | (주)라이브맥스 | Ｃｌａ가 함유된 재구성 지질의 제조방법 및 이용방법 |
| US7595378B2 (en) | 2001-06-13 | 2009-09-29 | Genmab A/S | Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| US20030044474A1 (en) * | 2001-08-03 | 2003-03-06 | Shaklee Corporation | High molecular weight, lipophilic, orally ingestible bioactive agents in formulations having improved bioavailability |
| JP3980851B2 (ja) * | 2001-08-30 | 2007-09-26 | 有限会社ゴトーコーポレーション | 固型製剤、その製造方法、及び食品 |
| US6811801B2 (en) | 2001-12-12 | 2004-11-02 | Abbott Laboratories | Methods and compositions for brightening the color of thermally processed nutritionals |
| US7247334B2 (en) * | 2002-03-18 | 2007-07-24 | Bunge Oils, Inc. | Low-residue, easy-cleaning and low-viscosity structured lipid pan release compositions and methods |
| US6793959B2 (en) * | 2002-03-18 | 2004-09-21 | Bunge Foods Corporation | Low viscosity structured lipid pan release compositions and methods |
| DE60238663D1 (de) * | 2002-04-05 | 2011-02-03 | Nestle Sa | Zusammensetzungen und Verfahren zur Verbesserung von Lipidassimilation in Haustieren |
| US20040115226A1 (en) * | 2002-12-12 | 2004-06-17 | Wenji Li | Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same |
| US20040115287A1 (en) * | 2002-12-17 | 2004-06-17 | Lipocine, Inc. | Hydrophobic active agent compositions and methods |
| US7041840B2 (en) * | 2002-12-18 | 2006-05-09 | Alberta Research Council Inc. | Antioxidant triacylglycerols and lipid compositions |
| US20060003002A1 (en) * | 2003-11-03 | 2006-01-05 | Lipocine, Inc. | Pharmaceutical compositions with synchronized solubilizer release |
| US20050196434A1 (en) * | 2004-03-04 | 2005-09-08 | Brierre Barbara T. | Pharmaceutical composition and method for the transdermal delivery of magnesium |
| US20050215640A1 (en) | 2004-03-26 | 2005-09-29 | Baxter Jeffrey H | HMB compositions and uses thereof |
| WO2005105040A2 (en) * | 2004-04-26 | 2005-11-10 | Micelle Products, Inc. | Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications |
| UA93985C2 (ru) | 2004-10-20 | 2011-03-25 | Эндорешерш, Инк. | Предшественники половых стероидов, одни или b сочетании c селективным модулятором эстрогенных рецепторов для лечения или снижения вероятности возникновения заболеваний или состояний влагалища у женщин b постменопаузе |
| US8492369B2 (en) | 2010-04-12 | 2013-07-23 | Clarus Therapeutics Inc | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
| KR20080009201A (ko) * | 2005-04-15 | 2008-01-25 | 클라루스 쎄러퓨틱스, 아이엔씨. | 소수성 약물의 약물전달시스템 및 이를 포함하는 조성물 |
| DK1871353T3 (da) * | 2005-04-15 | 2011-04-04 | Einstein Coll Med | Vitamin k til forebyggelse eller behandling af hududslæt sekundært til anti-EGFR-terapi |
| US20070218183A1 (en) * | 2006-03-14 | 2007-09-20 | Bunge Oils, Inc. | Oil composition of conjugated linoleic acid |
| CN104073505A (zh) | 2006-03-15 | 2014-10-01 | Dsmip资产公司 | 利用pufa聚酮化合物合成酶系统在异源的生物体中产生多不饱和脂肪酸的方法 |
| JP2009537640A (ja) * | 2006-05-17 | 2009-10-29 | ジスコート・ナムローゼ・フエンノートシャップ | 生体適合性コーティングの作製用脂肪酸トリグリセリド |
| CA2656613A1 (en) * | 2006-07-03 | 2008-01-10 | Genmab A/S | Prevention of rash in patients undergoing anti-egfr therapy |
| CA2558202A1 (en) * | 2006-09-14 | 2006-11-23 | Reinhold W. Vieth | Vitamin d compositions and method of administration to infants |
| US8268806B2 (en) * | 2007-08-10 | 2012-09-18 | Endorecherche, Inc. | Pharmaceutical compositions |
| US8206772B2 (en) * | 2007-11-08 | 2012-06-26 | Kraft Foods Global Brands Llc | Structured lipid compositions and methods of formulation thereof |
| US8815953B2 (en) * | 2008-03-13 | 2014-08-26 | Spectrum Pharmaceuticals, Inc. | Formulations of vitamin K analogs for topical use |
| CA2718416C (en) * | 2008-03-13 | 2018-01-02 | Mallinckrodt Inc. | Multi-function, foot-activated controller for imaging system |
| US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
| US9545117B2 (en) * | 2009-02-03 | 2017-01-17 | Tropicana Products, Inc. | Microencapsulated citrus phytochemicals and application to beverages |
| US20100196554A1 (en) * | 2009-02-03 | 2010-08-05 | Tropicana Products, Inc. | Microencapsulated citrus phytochemicals comprising citrus limonoids and application to beverages |
| US20100196549A1 (en) * | 2009-02-03 | 2010-08-05 | Tropicana Products, Inc. | Microencapsulated citrus phytochemicals and application to sports drinks |
| US20100196577A1 (en) * | 2009-02-03 | 2010-08-05 | Tropicana Products, Inc. | Microencapsulated citrus phytochemicals comprising citrus limonoids and application to sports drinks |
| CN102741267B (zh) | 2009-03-19 | 2020-06-23 | 帝斯曼知识产权资产有限公司 | 多不饱和脂肪酸合酶核酸分子和多肽，及其组合物、制备方法和用途 |
| TW201112967A (en) | 2009-09-16 | 2011-04-16 | Abbott Lab | Dryblended nutritional powders |
| TW201121431A (en) * | 2009-12-01 | 2011-07-01 | Abbott Lab | Soy protein-based nutritional formula with superior stability |
| TWI492744B (zh) * | 2009-12-04 | 2015-07-21 | Abbott Lab | 使用類胡蘿蔔素調節早產兒發炎症之方法 |
| EP2525811B2 (en) | 2010-01-19 | 2019-02-27 | Abbott Laboratories | A composition comprising lactobacillus rhamnosus hn001 and prebiotics for use in the treatment of allergic lung disease |
| WO2011126891A2 (en) * | 2010-03-30 | 2011-10-13 | Kraft Foods Global Brands Llc | Lipid compositions for increased fatty and creamy mouthfeel and uses thereof |
| EP2397038A1 (en) | 2010-06-21 | 2011-12-21 | Abbott Laboratories | Early programming of brain function through soy protein feeding |
| EP2422629A1 (en) | 2010-08-23 | 2012-02-29 | Abbott Laboratories | Methods for enhancing cognition and/or memory using maltodextrins |
| US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
| CN103327836B (zh) | 2010-12-29 | 2016-08-10 | 雅培制药有限公司 | 降低婴儿、幼儿或儿童的坏死性小肠结肠炎、腹痛和短肠综合征的发病率的方法 |
| US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
| NL2007268C2 (en) | 2011-08-16 | 2013-02-19 | Friesland Brands Bv | Nutritional compositions comprising human milk oligosaccharides and uses thereof. |
| US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
| EP3469912A1 (en) | 2012-12-20 | 2019-04-17 | Abbott Laboratories | Nutritional formulations using human milk oligosaccharides for modulating inflammation |
| EP4578865A3 (en) | 2014-08-12 | 2025-07-30 | Monash University | Lymph directing prodrugs |
| WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
| WO2016033556A1 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS |
| WO2016205423A2 (en) | 2015-06-15 | 2016-12-22 | Lipocine Inc. | Composition and method for oral delivery of androgen prodrugs |
| CN114031658A (zh) | 2015-09-08 | 2022-02-11 | 莫纳什大学 | 定向淋巴的前药 |
| BR112018006361B1 (pt) | 2015-10-01 | 2022-09-20 | FrieslandCampina Nederland B.V | Composição nutricional líquida termotratada, composição de proteína compreendendo caseína micelar e proteína do soro hidrolisada e método para a fabricação da mesma |
| EP3544614A4 (en) | 2016-11-28 | 2020-08-05 | Lipocine Inc. | TESTOSTERONE UNDECANOATE ORAL TREATMENT |
| WO2019046491A1 (en) | 2017-08-29 | 2019-03-07 | Ariya Therapeutics, Inc. | LIPIDIC PRODRUGS DIRECTING TO THE LYMPHATIC SYSTEM |
| US11883497B2 (en) | 2017-08-29 | 2024-01-30 | Puretech Lyt, Inc. | Lymphatic system-directing lipid prodrugs |
| WO2019086407A1 (en) | 2017-10-30 | 2019-05-09 | Frieslandcampina Nederland B.V. | Protein-dense nutritional compositions for use in treating and/or preventing a condition linked to loss of muscle mass and/or strength |
| US11608345B1 (en) | 2017-12-19 | 2023-03-21 | Puretech Lyt, Inc. | Lipid prodrugs of rapamycin and its analogs and uses thereof |
| US11304954B2 (en) | 2017-12-19 | 2022-04-19 | Puretech Lyt, Inc. | Lipid prodrugs of mycophenolic acid and uses thereof |
| EP3727362A4 (en) | 2017-12-19 | 2021-10-06 | PureTech LYT, Inc. | MYCOPHENOLIC ACID LIPID MEDICINAL PRODUCTS AND THEIR USES |
| CA3107214A1 (en) | 2018-07-20 | 2020-01-23 | Lipocine Inc. | Liver disease |
| AU2018440781A1 (en) * | 2018-09-11 | 2021-04-22 | Parapharm Development Limited | Capsule, tablet or pill |
| WO2020056430A1 (en) | 2018-09-14 | 2020-03-19 | PureTech Health LLC | Deuterium-enriched pirfenidone and methods of use thereof |
| CA3166908A1 (en) | 2020-02-05 | 2021-08-12 | Daniel Kenneth BONNER | Lipid prodrugs of neurosteroids |
| US20230149542A1 (en) | 2020-04-06 | 2023-05-18 | Abbott Laboratories | Nutritional formulations for modulating respiratory-induced cytokines |
| WO2022177965A1 (en) | 2021-02-16 | 2022-08-25 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin |
| WO2022226311A1 (en) | 2021-04-23 | 2022-10-27 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and a designed lipid component for improving lung function |
| WO2022266058A1 (en) | 2021-06-14 | 2022-12-22 | Abbott Laboratories | Methods and compositions for treating gas |
| WO2023159093A1 (en) | 2022-02-16 | 2023-08-24 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4871768A (en) * | 1984-07-12 | 1989-10-03 | New England Deaconess Hospital Corporation | Dietary supplement utilizing ω-3/medium chain trigylceride mixtures |
| EP0193602A1 (en) * | 1984-09-13 | 1986-09-10 | Center For Nutritional Research Charitable Trust | Triglyceride preparations for the prevention of catabolism |
| US4753963A (en) * | 1985-09-26 | 1988-06-28 | The Procter & Gamble Company | Nutritional fat suitable for enteral and parenteral products |
| US5081105A (en) * | 1988-01-15 | 1992-01-14 | New England Deaconess Hospital Corporation | Method of treating cancer using structured lipids |
| JP2677613B2 (ja) * | 1988-06-24 | 1997-11-17 | エーザイ株式会社 | ビタミンｅ又はその誘導体の吸収促進組成物 |
| US5601860A (en) * | 1990-11-30 | 1997-02-11 | American Home Products Corporation | Corandomized fat compositions for infant formulas |
| WO1992019237A1 (en) * | 1991-05-08 | 1992-11-12 | Novo Nordisk A/S | Use of a lipid for production of a pharmaceutical enteral preparation for treatment of lipid malabsorption |
| CA2151820C (en) * | 1993-01-15 | 2000-11-28 | Stephen Joseph Demichele | Structured lipids |
| AU683027B2 (en) * | 1993-01-27 | 1997-10-30 | Scotia Holdings Plc | Triglycerides |
| DE4417851C1 (de) * | 1994-05-20 | 1995-10-05 | Horst Heirler | Diätetisches Lebensmittel mit mittelkettigen Fettsäuren und dessen Verwendung |
| US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
-
1997
- 1997-12-16 US US08/991,503 patent/US6013665A/en not_active Expired - Lifetime
-
1998
- 1998-12-04 AT AT98960729T patent/ATE250938T1/de not_active IP Right Cessation
- 1998-12-04 CA CA002315224A patent/CA2315224A1/en not_active Abandoned
- 1998-12-04 BR BR9813474-4A patent/BR9813474A/pt not_active Application Discontinuation
- 1998-12-04 WO PCT/US1998/025741 patent/WO1999030740A1/en active IP Right Grant
- 1998-12-04 NZ NZ503666A patent/NZ503666A/en unknown
- 1998-12-04 JP JP2000538718A patent/JP2002508336A/ja active Pending
- 1998-12-04 TR TR2000/01563T patent/TR200001563T2/xx unknown
- 1998-12-04 EP EP98960729A patent/EP1037666B1/en not_active Expired - Lifetime
- 1998-12-04 DK DK98960729T patent/DK1037666T3/da active
- 1998-12-04 DE DE69818704T patent/DE69818704T2/de not_active Expired - Fee Related
- 1998-12-04 AU AU16256/99A patent/AU739233B2/en not_active Ceased
- 1998-12-04 PT PT98960729T patent/PT1037666E/pt unknown
- 1998-12-04 PL PL98341208A patent/PL341208A1/xx unknown
- 1998-12-04 IL IL13527198A patent/IL135271A0/xx unknown
- 1998-12-04 ES ES98960729T patent/ES2209228T3/es not_active Expired - Lifetime
- 1998-12-04 HU HU0100430A patent/HUP0100430A2/hu unknown
-
1999
- 1999-09-01 US US09/388,331 patent/US6160007A/en not_active Expired - Lifetime
-
2000
- 2000-04-28 NO NO20002306A patent/NO20002306L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE250938T1 (de) | 2003-10-15 |
| JP2002508336A (ja) | 2002-03-19 |
| DK1037666T3 (da) | 2004-02-09 |
| NZ503666A (en) | 2002-03-01 |
| PL341208A1 (en) | 2001-03-26 |
| AU739233B2 (en) | 2001-10-04 |
| BR9813474A (pt) | 2000-10-10 |
| DE69818704D1 (de) | 2003-11-06 |
| WO1999030740A1 (en) | 1999-06-24 |
| HUP0100430A2 (hu) | 2001-08-28 |
| IL135271A0 (en) | 2001-05-20 |
| NO20002306L (no) | 2000-06-16 |
| DE69818704T2 (de) | 2004-07-29 |
| AU1625699A (en) | 1999-07-05 |
| EP1037666A1 (en) | 2000-09-27 |
| US6013665A (en) | 2000-01-11 |
| ES2209228T3 (es) | 2004-06-16 |
| TR200001563T2 (tr) | 2000-10-23 |
| HK1032744A1 (en) | 2001-08-03 |
| CA2315224A1 (en) | 1999-06-24 |
| EP1037666B1 (en) | 2003-10-01 |
| NO20002306D0 (no) | 2000-04-28 |
| US6160007A (en) | 2000-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1037666E (pt) | Metodo para aumentar a absorcao e o transporte de compostos lipidicos soluveis usando gliceridos estruturados | |
| EA200001125A1 (ru) | Гелеобразные фармацевтические композиции | |
| MX9100229A (es) | Composiciones alimenticias y farmaceuticas que contienen acidos grasos monoinsaturados de cadena corta,y metodos de uso | |
| RU93058379A (ru) | Фармацевтическая композиция, содержащая определенную липидную систему, способ получения композиции и ее применение | |
| NZ301681A (en) | composition containing an emulsion comprising fatty acid derivatives and a compound of vegetal origin which can be used to modify the behaviour of cats | |
| MY111841A (en) | Injectable liposomal pharmaceutical preparations | |
| AP2000001943A0 (en) | Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent. | |
| ES2185179T3 (es) | Preparacion de composiciones farmaceuticas. | |
| FI972431A7 (fi) | Sytotoksisten T-lymfosyyttivasteiden induktio | |
| ATE117547T1 (de) | Orale lipidarzneiform. | |
| HUT75513A (en) | Taxane class derivative based pharmaceutical compositions and their preparation | |
| IT1187687B (it) | Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi | |
| KR900012612A (ko) | 제약 조성물 | |
| RU93053905A (ru) | Оксипуриновые нуклеозиды и родственные им соединения, а также их ацильные производные для улучшения гемопоэза, фармацевтическая композиция и способ лечения и/или профилактики | |
| SE9602280D0 (sv) | Immunstimulerande lipidformulering | |
| PT1057826E (pt) | Derivados carboxamidicos dimericos substituidos processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
| WO1998032428A3 (en) | Compositions comprising choline and use of choline to treat endotoxic shock | |
| RU93039185A (ru) | Эмульсионный концентрат | |
| BR9916156A (pt) | Método e composição para a manutenção e restituição de integridade do intestino | |
| RU2000108267A (ru) | Фармацевтические композиции на основе нестероидных противовоспалительных средств | |
| RU2006107197A (ru) | Применение омега-3 жирных кислот при лечении остеоартрита у псовых | |
| Haag-Grönlund et al. | Promotion of enzyme altered foci in female rat livers by 2, 3, 3′, 4, 4′, 5-hexachlorobiphenyl | |
| KR970705397A (ko) | 골다공증 치료를 위한 에스트로젠 화합물 및 부갑상선 호르몬(estrogens and parathyroid hormone for treating osteoporosis) | |
| KR970061084A (ko) | 닭의 발육을 촉진하는 방법 | |
| PT100526A (pt) | Agentes quimioterapeuticos de origem vegetal com actividade antineoplastica, possuindo selectividade elevada e toxicidade bastante reduzida e processo para a sua preparacao |